SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-068107
Filing Date
2019-03-08
Accepted
2019-03-08 08:10:32
Documents
3
Period of Report
2019-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d720531d8k.htm 8-K 15579
2 EX-99.1 d720531dex991.htm EX-99.1 46067
3 GRAPHIC g720531g89c08.jpg GRAPHIC 5379
  Complete submission text file 0001193125-19-068107.txt   70308
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38693 | Film No.: 19667636
SIC: 2836 Biological Products, (No Diagnostic Substances)